Latest Leadership News

Medallion Metals has executed a binding agreement to acquire the Forrestania Nickel Operation from IGO, expanded its Ravensthorpe gold-copper resource to nearly 1 million ounces gold equivalent, and secured a $50 million prepayment facility with Trafigura to advance project development.

Arovella Therapeutics reported solid progress in Q1 FY26, moving closer to initiating its first-in-human trial for ALA-101 while securing key patents and maintaining a strong cash position.

Locksley Resources appoints Kerrie Matthews as Managing Director and CEO to spearhead the commercialisation of U.S.-produced antimony, following a landmark domestic metal ingot milestone.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Dalaroo Metals has broadened its gold footprint in Côte d’Ivoire with four new project acquisitions while completing initial exploration in Greenland’s critical minerals sector. A $1 million capital raise supports these strategic moves as leadership changes unfold.

Vital Metals has raised A$6.8 million through a strategic placement and refreshed its board to accelerate development of its Nechalacho Rare Earths and Niobium Project in Canada, with further funding pending shareholder approval.

Peter Warren Automotive reports a strong FY25 with underlying profit before tax of $22.3 million, driven by disciplined inventory and cost management. The company declares a 4 cent fully franked dividend and signals confidence in growth through innovation and acquisitions.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir and is progressing regulatory discussions with the FDA to fast-track approval using the Animal Rule, backed by compelling preclinical data.

Caravel Minerals has appointed Primero Group as its preferred EPCM firm and secured a $15 million loan to fund its Definitive Feasibility Study, marking significant progress toward a Final Investment Decision for the Caravel Copper Project.

Sparc Technologies has completed construction of a pioneering green hydrogen pilot plant and secured new patents, while its graphene additive trials show promising corrosion resistance results.

Noxopharm Limited reports growing interest in its Sofra technology with new research collaborations and a safe, well-tolerated HERACLES trial of SOF-SKN. The company also secures funding extensions to support ongoing development.

PhosCo has received a €1 million grant from the European Bank for Reconstruction and Development alongside a $1.1 million investment from its Managing Director, fueling optimisation efforts ahead of the Gasaat Phosphate Project’s bankable feasibility study.